UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GC makes plasma Covid-19 therapy for clinical trials
GC Pharma has taken the first step to commercialize its new plasma treatmen...
by Shim Hyun-tai
|
2020-07-20 17:30
라인
Will interferon blocker work on severe Covid-19 patients?
An interferon blocker might help treat patients with severe Covid-19 infect...
by Kim Eun-young
|
2020-07-20 14:53
라인
New virus cases fell to 3-week low
Korea's new Covid-19 cases fell below 30 on Monday for the first time s...
by Shim Hyun-tai
|
2020-07-20 13:40
라인
KHIDI warns of impersonation fraud on website
The Korea Health Industry Development Institute (KHIDI) said it would preve...
by Kwak Sung-sun
|
2020-07-20 11:43
라인
Eutilex’s cancer therapy won Canadian patent
Eutilex, a biotechnology firm specializing in cancer immunotherapy, said Fr...
by Shim Hyun-tai
|
2020-07-17 17:52
라인
'Diabetes independent risk factor for severe, critical Covid-19 outcomes’
Researchers at Yeungnam University Medical Center have found that diabetes ...
by Lee Han-soo
|
2020-07-17 17:44
라인
Chunlab launches new platform to trace mutated Covid-19 virus
Microbiome database company Chunlab said it has launched "EzCOVID19," an ep...
by Shim Hyun-tai
|
2020-07-17 17:44
라인
Doctors, pharmacists push to thwart insurance benefits for herbal medicines
The medical community and pharmacist groups spoke with one voice to block h...
by Choi Gwang-seok
|
2020-07-17 15:54
라인
Junior nurses still bullied despite anti-harassment law
“You’re coming to work too late. Get to work three hours earlier.” “Don’t t...
by Kwak Sung-sun
|
2020-07-17 15:40
라인
Celltrion’s Covid-19 diagnostic kit gets CE certification
Celltrion said that its Covid-19 antigen diagnostic kit has won EU’s Confor...
by Lee Han-soo
|
2020-07-17 15:39
라인
New virus cases hover around 60
Korea’s new Covid-19 cases stayed around 60 for the second straight day on ...
by Lee Han-soo
|
2020-07-17 12:45
라인
EIU report assesses rare disease situations in Asia-Pacific
The Economist Intelligence Unit published a report Thursday, analyzing chal...
by Shim Hyun-tai
|
2020-07-16 17:58
라인
‘Obese people more vulnerable to Covid-19’
A researcher at Seoul National University Bundang Hospital and the compilin...
by Lee Han-soo
|
2020-07-16 17:30
라인
SNUH develops new nanoparticle to improve hyperthermia treatment for cancer
A research team at the Seoul National University Hospital (SNUH) has develo...
by Lee Han-soo
|
2020-07-16 16:39
라인
Leukemia patients suffer from shortage of platelet donors
Leukemia patients are finding it increasingly difficult to get timely plate...
by Song Soo-youn
|
2020-07-16 15:58
라인
Hanmi’s fatty liver drug won FDA’s fast-track designation
Hanmi Pharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Shim Hyun-tai
|
2020-07-16 15:57
라인
Genbody to export 2nd Covid-19 diagnostic kit
Genbody said Thursday that it will launch "GenBody COVID-19 Ag," a rapid an...
by Lee Han-soo
|
2020-07-16 14:39
라인
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
“Before Imfinzi arrived, all physicians could do for a state-3 unresectable...
by Kim Yun-mi
|
2020-07-16 14:37
라인
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk
|
2020-07-16 14:16
라인
Unrelenting imported cases push up Covid-19 outbreaks
Korea's new virus cases rose above 60 on Thursday, as imported infectio...
by Lee Han-soo
|
2020-07-16 11:44
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top